The Gross Margin of Orchard Therapeutics PLC (ORTX) is 70.08%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-12-31 | 70.08% |
2021-12-31 | 86.31% |
2020-12-31 | 66.92% |
2019-12-31 | 67.73% |
2018-12-31 | 79.81% |